BACKGROUND: Clinical observations on the potential of pre-hospital antiplatelet therapy in
preventing ARDS have been inconsistent. To further the correlation between antiplatelet …

Background Acute lung injury (ALI) is a potentially fatal lung disease with few treatment
options. Platelet activation is a key component of ALI pathophysiology and may provide an …

Background Antiplatelet agents are commonly used for cardiovascular diseases, but their
pleiotropic effects in critically ill patients are controversial. We therefore performed a meta …

Background Recent studies have shown that prior antiplatelet drug use could ameliorate the
risk and mortality of acute respiratory distress syndrome (ARDS). However, the connection …

Aim: Platelet function is intricately linked to the pathophysiology of critical Illness, and some
studies have shown that antiplatelet therapy (APT) may decrease mortality and incidence of …

Importance Management of acute respiratory distress syndrome (ARDS) remains largely
supportive. Whether early intervention can prevent development of ARDS remains unclear …

Background Antiplatelet agents are widely used for cardiovascular disea ses, but their
pleiotropic effects in sepsis are controversial. Objective To investigate the association …

Objectives: Platelet activation plays an active role in the pathogenesis of acute respiratory
distress syndrome. In our prior study of 575 patients at high risk for acute respiratory distress …

Abstract Background Acute Respiratory Distress Syndrome (ARDS) is a severe condition
with high mortality and morbidity rates. Evidence on the effectiveness of pharmacological …

Objective: To evaluate the association between prehospitalization aspirin therapy and
incident acute lung injury in a heterogeneous cohort of at-risk medical patients. Design: This …